Endocrine Society Endorses Bipartisan INSULIN Act to Expand Affordability and Market Competition
The Endocrine Society has officially announced its endorsement of the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN)…
disease management
Amara Maple Rethinking Obesity Management: Dr. Zeb I. Saeed Outlines a Patient-Centric Framework for Clinical Practice
The clinical landscape of obesity management is undergoing a significant paradigm shift, moving away from a purely metrics-driven approach toward…
FDA Approves Once-Weekly Insulin and New AI Platform Launches as Rare Disease Treatments Advance in Endocrine Health
The landscape of endocrine medicine underwent a significant transformation this month as the U.S. Food and Drug Administration (FDA) issued…
The Evolving Landscape of Obesity Management Advances in GLP-1 Therapies and Person Centered Care
The global medical community is witnessing a transformative shift in the approach to the obesity epidemic, transitioning from a historical…
Cultivating the Future of Endocrinology Through Strategic Mentorship and Career Development Initiatives
The Endocrine Society has announced a comprehensive expansion of its professional development portfolio, signaling a robust commitment to addressing the…
Defining Disease or Delaying Care? A Conceptual and Clinical Appraisal of the Lancet Obesity Framework
The global medical community is currently engaged in a rigorous debate over the fundamental definition of obesity, a discussion that…
FDA Approves Lilly’s Foundayo Weight Loss GLP-1 Pill and Viridian Announces Positive Topline Results in TED Clinical Trial
In a landmark week for the pharmaceutical industry, the U.S. Food and Drug Administration (FDA) has granted approval for a…
Navigating the Lifelong Challenges of Congenital Adrenal Hyperplasia From Pediatric Growth to Adult Metabolic Management
In the specialized corridors of endocrine clinics, medical professionals and patients engage in a daily, high-stakes balancing act. This clinical…
Endocrine Society Advocates for Robust NIH Funding and Expanded Access to Obesity Treatments Amid Ongoing Federal Budget Deliberations
In a significant mobilization of scientific and medical expertise, the Endocrine Society recently concluded a high-impact virtual Hill Day, marking…
Beyond the Curve: How XLH Impacts Skeletal Maturation and Predicted Height
Understanding the Pathophysiology of X-linked Hypophosphatemia At its core, XLH is a rare genetic disorder typically driven by mutations in…
